Background A 59-year-old female presented with a history of recurrent superficial bladder cancer. Since the initial diagnosis 12 years earlier, she had had 12 recurrences, all treated with ...

Patients with high-grade transitional cell carcinoma (TCC) of the bladder are currently treated with transurethral resection (TUR) and intravesical bacillus Calmette–Guérin (BCG) therapy, or with ...

Planning outcomes and acute toxicity of intensity-modulated radiotherapy (IMRT) for treatment of bladder and pelvic lymph nodes. Randomized phase II multicenter study of the efficacy and safety of ...

Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ ...

Multiple therapeutic options are available for the management of patients with upper urinary tract transitional cell carcinoma (TCC). Radical nephroureterectomy with an ipsilateral bladder cuff is the ...

Chemotherapy should be immediate after TUR in patients with non-muscle invasive disease. Bladder cancer is projected to be the fourth most common cancer diagnosed in 2007 and the eighth most common ...

WESTMINSTER, Colo.--(BUSINESS WIRE)-- Allos Therapeutics, Inc. (Nasdaq: ALTH) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to pralatrexate for ...

A new study suggests that firefighters may be at an increased risk of developing transitional cell carcinoma (TCC, or bladder cancer). Firefighters, who are regularly exposed to smoke and chemical ...